YY1-mediated downregulation of PGC-1β expression in turn attenuates MCAD and LCAD levels, leading to the suppression of fatty acid β-oxidation and subsequently lipid accumulation. Here, PPARGC1B is linked to medium chain acyl-CoA dehydrogenase deficiency.